ASCO: Simcere Targets Suvemcitug OS Win In Platinum-Resistant Ovarian Cancer

ovarian cancer
Platinum-resistant ovarian cancer has a mostly poor prognosis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from ASCO

More from Conferences